Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...

Sangamo Therapeutics (SGMO) announced it has entered into a license agreement with Eli Lilly (LLY), allowing Lilly to leverage Sangamo’s novel ...

RICHMOND, CA, USA I April 03, 2025 I Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced it has entered into a license ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.

H.C. Wainwright keeps a Buy rating on Tenaya Therapeutics (TNYA) with a $5 price target after the company presented an interim update from the ...

Recent advancements in biosensing technologies have paved the way for revolutionary diagnostic and treatment methods that prioritize speed, accuracy, and ...

Horizontal gene transfer (HGT) is the movement of genetic material from one organism to another. In this article, we will ...

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

ABSTRACT: Diabetes mellitus (DM) is associated with increased bone fragility despite normal or elevated bone mineral density, partially due to the accumulation of advanced glycation end products (AGEs ...

Eight metastasis-suppressor genes have been confirmed so far. They affect many aspects of signal transduction, including pathways that are involved in invasion, growth-factor-receptor signalling ...

Resultantly, developments of recombinant viral vectors with improved transduction efficiency and further methodological improvements have mostly focused on murine tissue, whereas AAVs successfully ...